{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:18:58Z","timestamp":1770067138373,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Fundacao de Amparo a Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jpba.2024.116458","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T16:50:53Z","timestamp":1725295853000},"page":"116458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ocular pharmacokinetics of acetazolamide from intravitreal implants by high-performance liquid chromatography coupled to tandem mass spectrometry"],"prefix":"10.1016","volume":"252","author":[{"given":"Pedro Henrique","family":"Reis da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus Augusto de","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela Coelho Silva","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduarda Diniz","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Eduardo","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rson Ant\u00f4nio","family":"Pianetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia Lig\u00f3rio","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando da Silva-Cunha","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116458_bib1","doi-asserted-by":"crossref","unstructured":"Jonas J.B., Aung T., Bourne R.R., Bron A.M., Ritch R., Panda-Jonas S. Glaucoma. Lancet. 2017;390(10108):2183-2193. doi: 10.1016\/S0140-6736(17)31469-1.","DOI":"10.1016\/S0140-6736(17)31469-1"},{"issue":"3","key":"10.1016\/j.jpba.2024.116458_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcjo.2012.02.003","article-title":"Epidemiology of glaucoma: what\u2019s new?","volume":"47","author":"Cook","year":"2012","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.jpba.2024.116458_bib3","doi-asserted-by":"crossref","unstructured":"Schmidl D., Schmetterer L., Garhofer G., Popa-Cherecheanu A. Pharmacotherapy of glaucoma. J Ocul Pharmacol Ther. 2015;31(2):63-77. doi: 10.1089\/jop.2014.0060.","DOI":"10.1089\/jop.2014.0067"},{"key":"10.1016\/j.jpba.2024.116458_bib4","doi-asserted-by":"crossref","unstructured":"Fuchshofer R., Tamm E.R. The role of TGF-\u03b2 in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res. 2012;347(1):279-290. doi: 10.1007\/s00441-011-1249-1.","DOI":"10.1007\/s00441-011-1274-7"},{"key":"10.1016\/j.jpba.2024.116458_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000458482","article-title":"Achievements and limits of current medical therapy of glaucoma","volume":"59","author":"Kalouda","year":"2017","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.jpba.2024.116458_bib6","doi-asserted-by":"crossref","unstructured":"Quigley H.A. Glaucoma, Lancet. 2011;377(9774):1367-1377. doi: 10.1016\/S0140-6736(10)61423-7.","DOI":"10.1016\/S0140-6736(10)61423-7"},{"key":"10.1016\/j.jpba.2024.116458_bib7","doi-asserted-by":"crossref","unstructured":"Aggarwal M., Boone C.D., Kondeti B., McKenna R. Structural Annotation of Human Carbonic Anhydrases, J. Enzyme Inhib. Med. Chem. 2013;28(2):267-277. doi: 10.3109\/14756366.2012.722816.","DOI":"10.3109\/14756366.2012.737323"},{"key":"10.1016\/j.jpba.2024.116458_bib8","doi-asserted-by":"crossref","unstructured":"Lusthaus J., Goldberg I. Current Management of Glaucoma. Med. J. Aust. 2019;210(4):180-187. doi: 10.5694\/mja2.50021.","DOI":"10.5694\/mja2.50020"},{"issue":"2","key":"10.1016\/j.jpba.2024.116458_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(00)00359-8","article-title":"Formulation and evaluation of ophthalmic preparations of acetazolamide","volume":"199","author":"Kaur","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jpba.2024.116458_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4155\/tde-2017-0087","article-title":"Cross-linked hyaluronan films loaded with acetazolamide-cyclodextrin-triethanolamine complexes for glaucoma treatment","volume":"9","author":"Calles","year":"2018","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jpba.2024.116458_bib11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1590\/S0004-27492003000700029","article-title":"Implantes biodegrad\u00e1veis destinados \u00e0 administra\u00e7\u00e3o intra-ocular","volume":"66","author":"Fialho","year":"2003","journal-title":"Arq. Bras. Oftalmol."},{"issue":"16","key":"10.1016\/j.jpba.2024.116458_bib12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.chroma.2009.09.053","article-title":"Recent advances in microextraction by packed sorbent for bioanalysis","volume":"1217","author":"Abdel-Rehim","year":"2010","journal-title":"J. Chromatogr. A"},{"issue":"3","key":"10.1016\/j.jpba.2024.116458_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jps.2600640309","article-title":"Assay for acetazolamide in plasma","volume":"64","author":"Bayne","year":"1975","journal-title":"J. Pharm Sci."},{"issue":"3","key":"10.1016\/j.jpba.2024.116458_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jps.2600690327","article-title":"Quantitation of acetazolamide in plasma by high-performance liquid chromatography","volume":"69","author":"Hossie","year":"1980","journal-title":"J. Pharm Sci."},{"issue":"1","key":"10.1016\/j.jpba.2024.116458_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0378-4347(00)80266-2","article-title":"Efficient extraction and reversed-phase high-performance liquid chromatography-ultraviolet quantitation of acetazolamide in serum","volume":"225","author":"Chambers","year":"1981","journal-title":"J. Chromatogr."},{"issue":"6","key":"10.1016\/j.jpba.2024.116458_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/02713688108998363","article-title":"Determination of acetazolamide in biological fluids by high-performance liquid chromatography","volume":"1","author":"Gal","year":"1981","journal-title":"Curr. Eye Res."},{"issue":"7","key":"10.1016\/j.jpba.2024.116458_bib17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jps.2600730732","article-title":"Determination of acetazolamide in biological fluids by reverse-phase high-performance liquid chromatography","volume":"73","author":"Chapron","year":"1984","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.jpba.2024.116458_bib18","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1080\/01483918508067157","article-title":"High-performance liquid chromatographic determination of acetazolamide in human plasma","volume":"8","author":"Hwang","year":"1985","journal-title":"J. Liq. Chromatogr."},{"key":"10.1016\/j.jpba.2024.116458_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-4347(00)80785-9","article-title":"Solid-phase extraction of acetazolamide from biological fluids and subsequent analysis by high-performance liquid chromatography","volume":"377","author":"Hartley","year":"1986","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2024.116458_bib20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2125.1989.tb03422.x","article-title":"Equivalence of conventional and sustained release oral dosage formulations of acetazolamide in primary open angle glaucoma","volume":"27","author":"Joyce","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116458_bib21","doi-asserted-by":"crossref","unstructured":"Herra\u00e9z-Hern\u00e1ndez R., Camp\u00edns-Falc\u00f3 P., Sevillano-Cabeza A. Determination of Acetazolamide in Human Urine Samples by Reversed-phase High-performance Liquid Chromatography in the Presence of Xanthines. J Chromatogr. 1992;582(1-2):181-187. doi: 10.1016\/0378-4347(92)80121-W.","DOI":"10.1016\/0378-4347(92)80317-J"},{"key":"10.1016\/j.jpba.2024.116458_bib22","doi-asserted-by":"crossref","unstructured":"Schwenck M.H., Peter W.L., Meese M.G., Singhal P.C. Acetazolamide Toxicity and Pharmacokinetics in Patients Receiving Hemodialysis, Pharmacotherapy. 1995;15(4):522-527. doi: 10.1002\/j.1875-9114.1995.tb02897.x.","DOI":"10.1002\/j.1875-9114.1995.tb04392.x"},{"key":"10.1016\/j.jpba.2024.116458_bib23","doi-asserted-by":"crossref","unstructured":"Yano I., Takayama A., Takano M., Inatani M., Tanihara H., Ogura Y., et al. Pharmacokinetics and Pharmacodynamics of Acetazolamide in Patients with Transient Intraocular Pressure Elevation, Eur. J. Clin. Pharmacol. 1998;54(1):63-68. doi: 10.1007\/s002280050418.","DOI":"10.1007\/s002280050422"},{"issue":"8","key":"10.1016\/j.jpba.2024.116458_bib24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0731-7085(98)00024-7","article-title":"Quantitation of acetazolamide in rat plasma, brain tissue and cerebrospinal fluid by high-performance liquid chromatography","volume":"17","author":"Ichikawa","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"8","key":"10.1016\/j.jpba.2024.116458_bib25","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2460\/ajvr.2000.61.965","article-title":"Pharmacokinetics of acetazolamide after intravenous and oral administration in horses","volume":"61","author":"Alberts","year":"2000","journal-title":"Am. J. Vet. Res."},{"issue":"1","key":"10.1016\/j.jpba.2024.116458_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0731-7085(01)00615-X","article-title":"Rapid determination of acetazolamide in human plasma","volume":"28","author":"Zarghi","year":"2002","journal-title":"J Pharm. Biomed. Anal"},{"issue":"1-2","key":"10.1016\/j.jpba.2024.116458_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpharm.2007.01.019","article-title":"Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor","volume":"338","author":"Aggarwal","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2024.116458_bib28","doi-asserted-by":"crossref","unstructured":"Seng Yue C., Huynh H.H., Raymond C., Charbonneau L., Roy L. Population Pharmacokinetic and Pharmacodynamic Modeling of Acetazolamide in Peritoneal Dialysis Patients and Healthy Volunteers, J. Pharm. Pharm. Sci. 2013;16(1):89-98. doi: 10.18433\/j3np4h.","DOI":"10.18433\/J3QG7Z"},{"issue":"9","key":"10.1016\/j.jpba.2024.116458_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0033-1363270","article-title":"Development and validation of a simple and reliable LC-MS\/MS method for the determination of acetazolamide, an effective carbonic anhydrase inhibitor, in plasma and its application to a pharmacokinetic study","volume":"64","author":"Li","year":"2014","journal-title":"Drug Res."},{"issue":"4","key":"10.1016\/j.jpba.2024.116458_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5530\/jyp.2015.4s.5","article-title":"LC\u2013MS\/MS assay for acetazolamide, a carbonic anhydrase inhibitor in human plasma and its clinical application","volume":"7","author":"Narapusetti","year":"2015","journal-title":"J. Young Pharm."},{"issue":"4","key":"10.1016\/j.jpba.2024.116458_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/JCP.0000000000000529","article-title":"A pharmacokinetic study examining acetazolamide as a novel adherence marker for clinical trials","volume":"36","author":"Hampson","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpba.2024.116458_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123336","article-title":"Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: in vivo distribution and safety of PHBV-ACZ nanoparticle","volume":"645","author":"Erdal","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jpba.2024.116458_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J Pharmacol. Pharmacother."},{"issue":"4","key":"10.1016\/j.jpba.2024.116458_bib34","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1208\/s12249-018-0978-3","article-title":"Etoposide-loaded poly(lactic-co-glycolic acid) intravitreal implants: in vitro and in vivo evaluation","volume":"19","author":"Solano","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.jpba.2024.116458_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10633-018-9664-8","article-title":"Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes","volume":"138","author":"De Paiva","year":"2019","journal-title":"Doc. Ophthalmol."},{"issue":"17","key":"10.1016\/j.jpba.2024.116458_bib36","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1055\/a-1223-2525","article-title":"Rosmarinic acid intravitreal implants: a new therapeutic approach for ocular neovascularization","volume":"86","author":"Vieira","year":"2020","journal-title":"Planta Med."},{"key":"10.1016\/j.jpba.2024.116458_bib37","first-page":"53878","article-title":"Use of rabbit eyes in pharmacokinetic studies of intraocular drugs","volume":"113","author":"Ahn","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jpba.2024.116458_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10633-023-09939-6","article-title":"Fernandes C Bastos, TMA, Scott IU, Fialho SL, Silva PHR, Messias A. Intravitreal acetazolamide implant for pseudophakic cystoid macular edema","volume":"147","author":"Jorge","year":"2023","journal-title":"Doc. Ophthalmol."},{"issue":"3","key":"10.1016\/j.jpba.2024.116458_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.jpba.2024.116458_bib40","unstructured":"Durairaj C., Kompella U.B. Biopharmaceutical Aspects of Ocular Drug Delivery. In: Mitra AK, editor. Ophthalmic Drug Delivery Systems. 2nd ed. New York: CRC Press; 2003. p. 59-80. doi:10.1201\/9781420043991.ch3."},{"issue":"12","key":"10.1016\/j.jpba.2024.116458_bib41","first-page":"2612","article-title":"Ocular pharmacokinetics of intraocular drug administration and the implications for the development of models for drug clearance","volume":"34","author":"Hutton-Smith","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2024.116458_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T19:26:03Z","timestamp":1730661963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524004989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"alternative-id":["S0731708524004989"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116458","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular pharmacokinetics of acetazolamide from intravitreal implants by high-performance liquid chromatography coupled to tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116458"}}